• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 954-968 of 973 results

1308 Exhibit: Exhibit 1308 Redacted McDuff Decl

Document IPR2023-00724, No. 1308 Exhibit - Exhibit 1308 Redacted McDuff Decl (P.T.A.B. Jun. 21, 2024)

cite Cite Document
Analyze

1314 Exhibit: Exhibit 1314 Redacted Vellturo Dep

Document IPR2023-00724, No. 1314 Exhibit - Exhibit 1314 Redacted Vellturo Dep (P.T.A.B. Jun. 21, 2024)

cite Cite Document
Analyze

2381 Exhibit: EX2381 Valentine, V, Goldman, J and Shubrook, JH, Rationale for, In...

Document IPR2023-00724, No. 2381 Exhibit - EX2381 Valentine, V, Goldman, J and Shubrook, JH, Rationale for, Initiation and Titration of the Basal InsulinGLP 1RA Fixed Ratio Combination Products, IDe...

cite Cite Document
Analyze

2456 Exhibit: EX2456 US Food Drug Administration, DrugsFDA, Adlyxin

Document IPR2023-00724, No. 2456 Exhibit - EX2456 US Food Drug Administration, DrugsFDA, Adlyxin (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2455 Exhibit: EX2455 Adlyxin Prescribing Information rev July 2016

Document IPR2023-00724, No. 2455 Exhibit - EX2455 Adlyxin Prescribing Information rev July 2016 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2011 Exhibit: EX2011 Declaration of George L Bakris, MD

Document IPR2023-00724, No. 2011 Exhibit - EX2011 Declaration of George L Bakris, MD (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2423 Exhibit: EX2423 US Food Drug Administration, DrugsFDA, Jentadueto®

Document IPR2023-00724, No. 2423 Exhibit - EX2423 US Food Drug Administration, DrugsFDA, Jentadueto® (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2655 Exhibit: EX2655 July 2, 2024 Email Thread Among Counsel for Petitioners My...

Document IPR2023-00724, No. 2655 Exhibit - EX2655 July 2, 2024 Email Thread Among Counsel for Petitioners Mylan, DRL, and Sun, and Counsel for Novo Regarding IPR2023 00724 – Service of draft p...

cite Cite Document
Analyze

2071 Exhibit: EX2071 Claim Construction Order, In re Ozempic Semaglutide Paten...

Document IPR2023-00724, No. 2071 Exhibit - EX2071 Claim Construction Order, In re Ozempic Semaglutide Patent Litigation, MDL No 22 MD 3038, Dkt No 148 D Del July 25, 2023 (P.T.A.B. Jan. 17, 2024...

cite Cite Document
Analyze

2373 Exhibit: EX2373 Cleveland Clinic, “GLP 1 Agonists,” httpsmyclevelandclinicor...

Document IPR2023-00724, No. 2373 Exhibit - EX2373 Cleveland Clinic, “GLP 1 Agonists,” httpsmyclevelandclinicorghealthtreatments13901 glp 1 agonists, last reviewed July 3, 2023 (P.T.A.B. Jan. 17, 20...

cite Cite Document
Analyze

1053 Exhibit: Moller 2011

Document IPR2023-00724, No. 1053 Exhibit - Moller 2011 (P.T.A.B. Mar. 16, 2023)

cite Cite Document
Analyze

1024 Exhibit: Drucker 2006

Document IPR2023-00724, No. 1024 Exhibit - Drucker 2006 (P.T.A.B. Mar. 16, 2023)

cite Cite Document
Analyze

1076 Exhibit: ClinicalTrials webpage

Document IPR2023-00724, No. 1076 Exhibit - ClinicalTrials webpage (P.T.A.B. Mar. 16, 2023)

cite Cite Document
Analyze

1008 Exhibit: Dalby CV

Document IPR2023-00724, No. 1008 Exhibit - Dalby CV (P.T.A.B. Mar. 16, 2023)

cite Cite Document
Analyze

1005 Exhibit: Jusko Decl

Document IPR2023-00724, No. 1005 Exhibit - Jusko Decl (P.T.A.B. Mar. 16, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 64 65 66 >>